Скачать или смотреть Tomorrow's Health: The Future of Cancer Immunotherapy

What are the latest cutting-edge developments in the fight against cancer?

Hear from experts from the academia, and the industry about the exciting developments and initiatives in Switzerland and how these aim to improve cancer patient treatment outcomes. The discussion will also shed light on both the scientific hurdles and the organizational challenges that the field is confronted with.

Meet the speakers:
Ana Maria Mendes Cerdeira, Ph.D.
VP, Strategic Planning and Portfolio Strategy of Molecular Partners

Andrea Alimonti, Prof. Dr.
Head, Molecular Oncology, Institute of Oncology Research, CH; Prof. of Experimental Oncology and Translational Cancer Medicine, ETH Zurich; Prof. of Oncology, Università della Svizzera Italiana Lugano; Prof. of Pharmacology, University of Padua, IT

Brian Hashemi, Dr.
Managing Partner, Salus Partners SA and Chairman, Novigenix SA

Marija Plodinec, Dr.
CEO, Board Member and Co-Founder of ARTIDIS

Lana Kandalaft, Pharma D., Ph.D.
Assistant Professor & Director, Center for Experimental Therapeutics, Department of Oncology, University of Lausanne; Tenure Track Assistant Professor, Ludwig Cancer Research Lausanne Branch

Pablo Umaña, Ph.D.
Head Cancer Immunotherapy Discovery, Roche Innovation Center Zurich (Roche Glycart AG)